# OnCo record paper-osimertinib-nsclc-n-engl-j-med-2020 (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-osimertinib-nsclc-n-engl-j-med-2020/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-osimertinib-nsclc-n-engl-j-med-2020" ;
  schema:name "Overall Survival with Osimertinib in Untreated, EGFR -Mutated Advanced NSCLC"@en ;
  schema:description "Phase 2 or 3 results paper on Osimertinib in Non-small-cell lung cancer, in New England Journal of Medicine (2020), one of the most cited Europe PMC records with Osimertinib in its title."@en ;
  schema:url <https://onco.cc/key-papers/paper-osimertinib-nsclc-n-engl-j-med-2020/> ;
  schema:dateModified "2026-09-22"^^xsd:date ;
  schema:citation <https://doi.org/10.1056/nejmoa1913662>, <https://pubmed.ncbi.nlm.nih.gov/31751012/>, <https://europepmc.org/article/MED/31751012>, <https://clinicaltrials.gov/study/NCT02296125> ;
  onco:tag "europepmc-ingest" ;
  schema:sameAs <https://doi.org/10.1056/nejmoa1913662> ;
  schema:datePublished "2020"^^xsd:gYear ;
  schema:author "Ramalingam SS, Vansteenkiste J, Planchard D, et al." ;
  onco:trials <https://onco.cc/trials/flaura/> ;
  onco:journals <https://onco.cc/journals/nejm/> .